Icon Plc (ICLR)

$169.86 +8.90 (5.53%)
Market Cap 13.01B
Revenue (ttm) 8.25B
Net Income (ttm) 229.34M
EPS (ttm) N/A
PE Ratio 16.30
Forward PE 17.17
Profit Margin 2.78%
Debt to Equity Ratio 0.37
Volume 1,443,100
Avg Vol 1,283,964
Day's Range N/A - N/A
Shares Out 76.57M
Stochastic %K 98%
Beta 1.26
Analysts Sell
Price Target $172.00

Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and p...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 353 1 291 2000
Fax: 353 1 247 6260
Address:
South County Business Park, Leopardstown, Dublin, Ireland
BillionerOfKing
BillionerOfKing Jun. 26 at 6:57 PM
$ICLR Current Stock Price: $168.30 Contracts to trade: $170.0 ICLR Jul 17 2026 Call Entry: $6.50 Exit: $12.09 ROI: 86% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
MaverikIT
MaverikIT Jun. 26 at 2:35 PM
@cynicaloptimist @BustaCapital @Jblack500 @IsabellaDC @WAJeff @No_Face_character $ICLR $TWST ing $NTRA - tagging on
2 · Reply
OpenOutcrier
OpenOutcrier Jun. 25 at 8:01 PM
RECAP 6/25 +Pos Comments: $ICLR + RBC Capital RECAP 6/25 -Neg Comments: $VELO - Morpheus $SILA - Truist Live Breaking trading news www.openoutcrier.com
0 · Reply
sandeeprk
sandeeprk Jun. 25 at 12:28 PM
$ICLR finally 😁
0 · Reply
Estimize
Estimize Jun. 24 at 12:03 PM
Wall St is expecting 2.56 EPS for $ICLR Q2 [Reporting 07/29 AMC] http://www.estimize.com/intro/iclr?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize Jun. 24 at 10:01 AM
$ICLR reported 2.50 EPS and 2,034 revenue for Q1. http://www.estimize.com/intro/iclr?chart=historical&metric_name=eps&utm_content=ICLR&utm_
0 · Reply
longDstyle
longDstyle Jun. 23 at 9:43 PM
$ICLR good time to short
0 · Reply
GreedyOne
GreedyOne Jun. 23 at 8:53 PM
$ICLR lol I guess everyone had puts
0 · Reply
longDstyle
longDstyle Jun. 23 at 8:33 PM
$ICLR yuck
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jun. 23 at 8:30 PM
$ICLR Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $1.37 down -31.50% YoY • Reported revenue of $2.03B up 0.93% YoY • ICON plc is reaffirming its 2026 full-year financial guidance, expecting revenue in the range of $7,850 to $8,150 million and adjusted diluted earnings per share between $10.00 and $11.00.
0 · Reply
Latest News on ICLR
Icon price target raised to $190 from $180 at Mizuho

2026-06-26T11:10:16.000Z - 3 days ago

Icon price target raised to $190 from $180 at Mizuho

Icon upgraded to Outperform from Sector Perform at RBC Capital

2026-06-25T14:05:28.000Z - 3 days ago

Icon upgraded to Outperform from Sector Perform at RBC Capital

Icon price target raised to $187 from $160 at BMO Capital

2026-06-25T12:55:19.000Z - 3 days ago

Icon price target raised to $187 from $160 at BMO Capital

Icon price target raised to $155 from $130 at JPMorgan

2026-06-25T11:30:10.000Z - 4 days ago

Icon price target raised to $155 from $130 at JPMorgan

Icon price target raised to $197 from $164 at TD Cowen

2026-06-25T11:15:20.000Z - 4 days ago

Icon price target raised to $197 from $164 at TD Cowen

Icon price target raised to $150 from $125 at BofA

2026-06-25T10:45:15.000Z - 4 days ago

Icon price target raised to $150 from $125 at BofA

Icon price target raised to $165 from $140 at Citi

2026-06-25T10:30:10.000Z - 4 days ago

Icon price target raised to $165 from $140 at Citi

Icon price target raised to $186 from $168 at Baird

2026-06-25T10:25:41.000Z - 4 days ago

Icon price target raised to $186 from $168 at Baird

Icon price target raised to $175 from $160 at Barclays

2026-06-25T08:55:19.000Z - 4 days ago

Icon price target raised to $175 from $160 at Barclays

ICON Public Limited Company Earnings Call Transcript: Q1 2026

Jun 24, 2026, 8:00 AM EDT - 5 days ago

ICON Public Limited Company Earnings Call Transcript: Q1 2026

ICON Public Limited Company Earnings release: Q1 2026

Jun 24, 2026, 8:00 AM EDT - 5 days ago

ICON Public Limited Company Earnings release: Q1 2026

ICON Public Limited Company Slides: Q1 2026

Jun 24, 2026, 8:00 AM EDT - 5 days ago

ICON Public Limited Company Slides: Q1 2026

Icon price target raised to $160 from $150 at Barclays

2026-06-24T08:55:41.000Z - 5 days ago

Icon price target raised to $160 from $150 at Barclays

Icon reports Q1 adjusted EPS $2.50, consensus $2.43

2026-06-23T20:22:47.000Z - 5 days ago

Icon reports Q1 adjusted EPS $2.50, consensus $2.43

Notable companies reporting after market close

2026-06-23T19:17:51.000Z - 5 days ago

Notable companies reporting after market close

CBRS FDX KBH WOR

Icon selects Microsoft as preferred technology partner

2026-06-22T11:26:51.000Z - 7 days ago

Icon selects Microsoft as preferred technology partner

MSFT

ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development

Jun 22, 2026, 7:00 AM EDT - 7 days ago

ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development

ICON

ICON Schedules First Quarter 2026 Earnings Conference Call

Jun 17, 2026, 4:15 PM EDT - 11 days ago

ICON Schedules First Quarter 2026 Earnings Conference Call

ICON Public Limited Company Earnings Call Transcript: Q4 2025

May 28, 2026, 8:00 AM EDT - 4 weeks ago

ICON Public Limited Company Earnings Call Transcript: Q4 2025

ICON Public Limited Company Annual report: Q4 2025

May 28, 2026, 8:00 AM EDT - 4 weeks ago

ICON Public Limited Company Annual report: Q4 2025

ICON Public Limited Company Earnings release: Q4 2025

May 28, 2026, 8:00 AM EDT - 4 weeks ago

ICON Public Limited Company Earnings release: Q4 2025

ICON Public Limited Company Slides: Q4 2025

May 28, 2026, 8:00 AM EDT - 4 weeks ago

ICON Public Limited Company Slides: Q4 2025

ICON Public Limited Company Annual report: Q4 2025

May 28, 2026, 8:00 AM EDT - 4 weeks ago

ICON Public Limited Company Annual report: Q4 2025

ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation

May 27, 2026, 4:33 PM EDT - 4 weeks ago

ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation

ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq

May 26, 2026, 4:05 PM EDT - 4 weeks ago

ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq

ICON expands US early phase research capabilities with new clinic and outpatient centres

May 13, 2026, 8:00 AM EDT - 6 weeks ago

ICON expands US early phase research capabilities with new clinic and outpatient centres

HealthVerity to Acquire Symphony Health, Uniting Clinical Data and Commercial Analytics to Accelerate Breakthroughs Across the Healthcare Ecosystem

May 5, 2026, 8:00 AM EDT - 7 weeks ago

HealthVerity to Acquire Symphony Health, Uniting Clinical Data and Commercial Analytics to Accelerate Breakthroughs Across the Healthcare Ecosystem

ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results

Apr 29, 2026, 7:00 AM EDT - 2 months ago

ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results

ICON and Advarra Introduce New ‘Research-Ready,' Connected Site Network Model

Mar 24, 2026, 8:00 AM EDT - 3 months ago

ICON and Advarra Introduce New ‘Research-Ready,' Connected Site Network Model

Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm

Mar 16, 2026, 11:02 AM EDT - 3 months ago

Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm

Ademi LLP Investigates Claims of Securities Fraud against ICON plc

Feb 26, 2026, 9:06 AM EST - 4 months ago

Ademi LLP Investigates Claims of Securities Fraud against ICON plc

ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement

Feb 18, 2026, 9:00 AM EST - 4 months ago

ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement

Why this drug-research company's stock is having its worst day since 1999

Feb 12, 2026, 11:10 AM EST - 4 months ago

Why this drug-research company's stock is having its worst day since 1999

ICON PLC (ICLR) Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Feb 12, 2026, 10:15 AM EST - 4 months ago

ICON PLC (ICLR) Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices

Feb 12, 2026, 6:00 AM EST - 4 months ago

ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices

ICON's Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership

Jan 27, 2026, 7:15 AM EST - 5 months ago

ICON's Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership

ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive

Dec 9, 2025, 7:15 AM EST - 7 months ago

ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

Dec 2, 2025, 7:15 AM EST - 7 months ago

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

ICON Public Limited Company Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 4:00 AM EST - 7 months ago

ICON Public Limited Company Transcript: Jefferies London Healthcare Conference 2025

ICON plc to Present at the Jefferies London Healthcare Conference

Nov 12, 2025, 6:45 AM EST - 8 months ago

ICON plc to Present at the Jefferies London Healthcare Conference

ICON Public Limited Company Earnings Call Transcript: Q3 2025

Oct 23, 2025, 8:00 AM EDT - 8 months ago

ICON Public Limited Company Earnings Call Transcript: Q3 2025

ICON Public Limited Company Earnings release: Q3 2025

Oct 23, 2025, 8:00 AM EDT - 8 months ago

ICON Public Limited Company Earnings release: Q3 2025

ICON Public Limited Company Slides: Q3 2025

Oct 23, 2025, 8:00 AM EDT - 8 months ago

ICON Public Limited Company Slides: Q3 2025

ICON Reports Third Quarter 2025 Results

Oct 22, 2025, 4:25 PM EDT - 8 months ago

ICON Reports Third Quarter 2025 Results

ICON plc Schedules Third Quarter 2025 Earnings Conference Call

Sep 24, 2025, 9:00 AM EDT - 9 months ago

ICON plc Schedules Third Quarter 2025 Earnings Conference Call

ICON Public Limited Company Transcript: Baird Global Healthcare Conference 2025

Sep 10, 2025, 1:25 PM EDT - 10 months ago

ICON Public Limited Company Transcript: Baird Global Healthcare Conference 2025

ICON Announces CEO Transition

Sep 4, 2025, 8:00 AM EDT - 10 months ago

ICON Announces CEO Transition

ICON plc to Participate at Upcoming Investor Conferences

Sep 2, 2025, 6:00 AM EDT - 10 months ago

ICON plc to Participate at Upcoming Investor Conferences

ICON Public Limited Company Earnings Call Transcript: Q2 2025

Jul 24, 2025, 8:00 AM EDT - 1 year ago

ICON Public Limited Company Earnings Call Transcript: Q2 2025

ICON Public Limited Company Earnings release: Q2 2025

Jul 24, 2025, 8:00 AM EDT - 1 year ago

ICON Public Limited Company Earnings release: Q2 2025

ICON Public Limited Company Slides: Q2 2025

Jul 24, 2025, 8:00 AM EDT - 1 year ago

ICON Public Limited Company Slides: Q2 2025

ICON Announces Results of Annual General Meeting

Jul 23, 2025, 4:20 PM EDT - 1 year ago

ICON Announces Results of Annual General Meeting

ICON Reports Second Quarter 2025 Results

Jul 23, 2025, 4:15 PM EDT - 1 year ago

ICON Reports Second Quarter 2025 Results

ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

Jul 16, 2025, 7:15 AM EDT - 1 year ago

ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

Jul 7, 2025, 7:15 AM EDT - 1 year ago

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

ICON plc Schedules Second Quarter 2025 Earnings Conference Call

Jun 23, 2025, 6:30 AM EDT - 1 year ago

ICON plc Schedules Second Quarter 2025 Earnings Conference Call

ICON Public Limited Company Transcript: 45th Annual William Blair Growth Stock Conference

Jun 4, 2025, 11:40 AM EDT - 1 year ago

ICON Public Limited Company Transcript: 45th Annual William Blair Growth Stock Conference

ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR

Jun 2, 2025, 4:12 AM EDT - 1 year ago

ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

May 27, 2025, 8:30 AM EDT - 1 year ago

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

ICON releases its ICON Cares 2024 Report

May 19, 2025, 4:15 PM EDT - 1 year ago

ICON releases its ICON Cares 2024 Report

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

May 7, 2025, 7:27 AM EDT - 1 year ago

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

ICON Public Limited Company Earnings Call Transcript: Q1 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

ICON Public Limited Company Earnings Call Transcript: Q1 2025

ICON Public Limited Company Earnings release: Q1 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

ICON Public Limited Company Earnings release: Q1 2025

ICON Public Limited Company Slides: Q1 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

ICON Public Limited Company Slides: Q1 2025

ICON Reports First Quarter 2025 Results

Apr 30, 2025, 4:15 PM EDT - 1 year ago

ICON Reports First Quarter 2025 Results

BillionerOfKing
BillionerOfKing Jun. 26 at 6:57 PM
$ICLR Current Stock Price: $168.30 Contracts to trade: $170.0 ICLR Jul 17 2026 Call Entry: $6.50 Exit: $12.09 ROI: 86% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
MaverikIT
MaverikIT Jun. 26 at 2:35 PM
@cynicaloptimist @BustaCapital @Jblack500 @IsabellaDC @WAJeff @No_Face_character $ICLR $TWST ing $NTRA - tagging on
2 · Reply
OpenOutcrier
OpenOutcrier Jun. 25 at 8:01 PM
RECAP 6/25 +Pos Comments: $ICLR + RBC Capital RECAP 6/25 -Neg Comments: $VELO - Morpheus $SILA - Truist Live Breaking trading news www.openoutcrier.com
0 · Reply
sandeeprk
sandeeprk Jun. 25 at 12:28 PM
$ICLR finally 😁
0 · Reply
Estimize
Estimize Jun. 24 at 12:03 PM
Wall St is expecting 2.56 EPS for $ICLR Q2 [Reporting 07/29 AMC] http://www.estimize.com/intro/iclr?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize Jun. 24 at 10:01 AM
$ICLR reported 2.50 EPS and 2,034 revenue for Q1. http://www.estimize.com/intro/iclr?chart=historical&metric_name=eps&utm_content=ICLR&utm_
0 · Reply
longDstyle
longDstyle Jun. 23 at 9:43 PM
$ICLR good time to short
0 · Reply
GreedyOne
GreedyOne Jun. 23 at 8:53 PM
$ICLR lol I guess everyone had puts
0 · Reply
longDstyle
longDstyle Jun. 23 at 8:33 PM
$ICLR yuck
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jun. 23 at 8:30 PM
$ICLR Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $1.37 down -31.50% YoY • Reported revenue of $2.03B up 0.93% YoY • ICON plc is reaffirming its 2026 full-year financial guidance, expecting revenue in the range of $7,850 to $8,150 million and adjusted diluted earnings per share between $10.00 and $11.00.
0 · Reply
1986iamwallstreet
1986iamwallstreet Jun. 23 at 8:27 PM
$ICLR guidance is weak 🩸🩸🩸🩸🩸🩸
0 · Reply
1986iamwallstreet
1986iamwallstreet Jun. 23 at 8:27 PM
$ICLR flush it weak numbers for a stock that’s up 22%. Let it bleed 🩸🩸🩸🩸🩸🩸🩸🩸🩸
1 · Reply
notreload_ai
notreload_ai Jun. 23 at 8:09 PM
Earnings Reports After Closing: $FDX, $CBRS, $KBH, $ICLR, $WOR.
0 · Reply
GreedyOne
GreedyOne Jun. 23 at 8:02 PM
$ICLR 125
0 · Reply
DonCorleone77
DonCorleone77 Jun. 23 at 7:17 PM
$FDX $CBRS $KBH $ICLR $WOR Some notable companies reporting after the market close, with earnings consensus estimates: - FedEx (FDX), consensus $5.95 - Cerebras Systems (CBRS), consensus (16c) - KB Home (KBH), consensus 46c - Icon plc (ICLR), consensus $2.43 - Worthington (WOR), consensus $1.06
0 · Reply
Profitrip
Profitrip Jun. 23 at 4:06 PM
$ICLR earnings after market / high IV should make a good move / direction is another story
0 · Reply
Estimize
Estimize Jun. 23 at 3:00 PM
$ICLR reports after the close, Estimize Consensus +0.51 EPS and -28.94M Revs compared to WS http://www.estimize.com/iclr/fq1-2026?utm_conte
0 · Reply
omarnike123
omarnike123 Jun. 15 at 7:47 PM
$ICLR when is earning ?
0 · Reply
Olddrache
Olddrache Jun. 9 at 6:59 PM
$ICLR Expected Move 6.2%
1 · Reply
jegade
jegade Jun. 9 at 3:40 PM
$ICLR what is the expected move @Olddrache
0 · Reply
NVDAMillionaire
NVDAMillionaire Jun. 5 at 5:40 PM
$ICLR Really good write-up that perfectly summarizes ICLR's present situation. So if you want to bring your ICLR knowledge up to date or just discover ICLR, this is required reading. https://everyticker.com/quote/ICLR/analysis/icon-s-ai-powered-turnaround-why-clinical-trial-automation-trumps-accounting-scandal-nasdaq-iclr
0 · Reply
Chortlemethis
Chortlemethis May. 29 at 11:36 PM
$ICLR d$ICLR does a plc have the same tax treatment as an mlp?
0 · Reply